|
⚲
|
| Keyboard |
| Baker Douglas P
✚
|
|
|---|---|
| CIK # | 0001028775 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001028775] | |
| 4 | [0001028775] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| Baker Douglas P | |
| Pen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptimizeRx Corp OPRX
Common Stock
|
2021-10-05 | Option exercise | 10,000 | $7.51 | 75,100 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-10-05 | Sell | 4,000 | $84.22 | 336,880 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-10-05 | Sell | 10,000 | $82.35 | 823,500 |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2021-10-05 | Option exercise | 10,000 | $7.51 | 75,100 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-09-28 | Sell | 2,000 | $74.66 | 149,320 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-09-21 | Sell | 4,000 | $70.59 | 282,360 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-09-14 | Sell | 3,768 | $65.57 | 247,068 |
|
OptimizeRx Corp OPRX
Common Stock
|
2021-09-08 | Option exercise | 10,000 | $7.51 | 75,100 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-09-08 | Sell | 10,000 | $67.25 | 672,500 |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2021-09-08 | Option exercise | 10,000 | $7.51 | 75,100 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-09-07 | Sell | 2,232 | $70.53 | 157,423 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-31 | Sell | 4,000 | $66.62 | 266,480 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-24 | Sell | 4,000 | $61.50 | 246,000 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-20 | Sell | 5,000 | $58.45 | 292,250 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-17 | Sell | 4,000 | $58.46 | 233,840 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-13 | Sell | 5,000 | $63.27 | 316,350 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-10 | Sell | 2,000 | $64.50 | 129,000 |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2021-08-09 | Option exercise | 10,000 | $7.51 | 75,100 |
|
OptimizeRx Corp OPRX
Common Stock
|
2021-08-09 | Option exercise | 10,000 | $7.51 | 75,100 |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-08-09 | Sell | 10,000 | $64.31 | 643,100 |
| showing 20 of 95 most recent transactions | |||||